PE20091781A1 - Uso de defensinas contra la meningitis - Google Patents

Uso de defensinas contra la meningitis

Info

Publication number
PE20091781A1
PE20091781A1 PE2009000481A PE2009000481A PE20091781A1 PE 20091781 A1 PE20091781 A1 PE 20091781A1 PE 2009000481 A PE2009000481 A PE 2009000481A PE 2009000481 A PE2009000481 A PE 2009000481A PE 20091781 A1 PE20091781 A1 PE 20091781A1
Authority
PE
Peru
Prior art keywords
amino acid
acid sequence
against meningitis
defensins against
defensins
Prior art date
Application number
PE2009000481A
Other languages
English (en)
Inventor
Hans-Henrik Kristensen Hoegenhaug
Dorthe Sandvang
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40875112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20091781(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novozymes As filed Critical Novozymes As
Publication of PE20091781A1 publication Critical patent/PE20091781A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE REFIERE A UN POLIPEPTIDO QUE ES UNA B-DEFENSINA CON ACTIVIDAD ANTIMICROBIANA QUE COMPRENDE UNA SECUENCIA DE AMINOACIDOS QUE TIENE EL 90% DE IDENTIDAD CON LA SECUENCIA DE AMINOACIDOS DE SEQ ID Nº: 1. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA QUE CONTIENE DICHO POLIPEPTIDO SIENDO UTIL PARA EL TRATAMIENTO DE MENINGITIS NEUMOCOCICA CAUSADA POR UNA INFECCION POR STREPTOCOCCUS PNEUMONIAE RESISTENTE A LA PENICILINA
PE2009000481A 2008-04-04 2009-04-02 Uso de defensinas contra la meningitis PE20091781A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08154103 2008-04-04

Publications (1)

Publication Number Publication Date
PE20091781A1 true PE20091781A1 (es) 2009-12-03

Family

ID=40875112

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2009000481A PE20091781A1 (es) 2008-04-04 2009-04-02 Uso de defensinas contra la meningitis

Country Status (18)

Country Link
US (1) US20090253629A1 (es)
EP (1) EP2278991A1 (es)
JP (1) JP2011516450A (es)
KR (1) KR20100134025A (es)
CN (1) CN102036678A (es)
AP (1) AP2010005403A0 (es)
AR (1) AR071177A1 (es)
AU (1) AU2009231463A1 (es)
BR (1) BRPI0909021A2 (es)
CA (1) CA2720380A1 (es)
CL (1) CL2009000811A1 (es)
EA (1) EA201071163A1 (es)
IL (1) IL208189A0 (es)
MX (1) MX2010010795A (es)
PE (1) PE20091781A1 (es)
TW (1) TW200942254A (es)
WO (1) WO2009121828A1 (es)
ZA (1) ZA201006645B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8846401A1 (es) * 2008-10-23 2010-05-26 Novozymes As Sinergismo antibiótico
TW201125577A (en) * 2009-12-02 2011-08-01 Novozymes As Use of defensins for treatment of infective endocarditis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338936B2 (en) * 2000-11-28 2008-03-04 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US20040265337A1 (en) * 2002-08-21 2004-12-30 Zsebo Krisztina M. Method of generating an immune response and compositions used for same
RU2393224C2 (ru) * 2004-11-12 2010-06-27 Новозимс Эдениум Байотек А/С Полипептиды с противомикробной активностью и кодирующие их полинуклеотиды
US20060217306A1 (en) * 2005-02-08 2006-09-28 Novozymes A/S Systemic treatment of infections with defensins
EP1891097B1 (en) * 2005-06-06 2016-11-16 Adenium Biotech ApS Polypeptides having antimicrobial activity and polynucleotides encoding same

Also Published As

Publication number Publication date
MX2010010795A (es) 2011-01-12
KR20100134025A (ko) 2010-12-22
CA2720380A1 (en) 2009-10-08
WO2009121828A1 (en) 2009-10-08
AP2010005403A0 (en) 2010-10-31
AU2009231463A1 (en) 2009-10-08
BRPI0909021A2 (pt) 2015-09-22
CL2009000811A1 (es) 2010-05-07
EP2278991A1 (en) 2011-02-02
JP2011516450A (ja) 2011-05-26
IL208189A0 (en) 2010-12-30
TW200942254A (en) 2009-10-16
AR071177A1 (es) 2010-06-02
US20090253629A1 (en) 2009-10-08
CN102036678A (zh) 2011-04-27
EA201071163A1 (ru) 2011-04-29
ZA201006645B (en) 2011-06-29

Similar Documents

Publication Publication Date Title
CY1120079T1 (el) Υδατικη συνθεση που περιεχει βρωμεξινη
CO6290770A2 (es) Nuevos derivados de insulina con perfil tiempo/accion extremadamente retardado
CY1118601T1 (el) Αλκυλαμινο-υποκατεστημενες δικυανοπυριδινες και προφαρμακα τυπου εστερα αμινοξεος αυτων
PE20170140A1 (es) Metodos para tratar el cancer con inhibidores de tigit y agentes contra el cancer
UA118167C2 (uk) Пептид та його застосування
CL2016001405A1 (es) A peptide mixture
BRPI0906478B8 (pt) anticorpo anti-nr10, seu uso e composição farmacêutica que o compreende
BR112012018951A8 (pt) anticorpo monoclonal, composição farmacêutica, combinação farmacêutica, uso de um anticorpo, uso de uma composição farmacêutica e uso de uma combinação farmacêutica
EA201000327A1 (ru) Белок
CO6460708A2 (es) Composiciones borínicas
PE20220960A1 (es) Proteinas de variantes de secuencias de aminoacidos de cry1da1 activas para lepidopteros
MX2010007670A (es) Uso de sal de acido acetilsalicilico para tratamiento de infecciones virales.
MX2011004483A (es) Leucolectinas y sus usos.
AR083126A1 (es) Composicion vacunal para el control de las infestaciones por ectoparasitos
BR112016016103A2 (pt) Composição de antígenos micobacterianos
AR100365A1 (es) Composición acuosa que comprende ibuprofeno y paracetamol en combinación, proceso para fabricarla y dispositivo inyector para administrarla
BR112014028130A2 (pt) Sal de cloridrato de um peptídeo, composição farmacêutica, uso de um sal de cloridrato, uso de uma composição farmacêutica, e, método para evitar ou tratar alergia a gatos
BR112018014175A2 (pt) composição antibacteriana e método para tratar infecções estafilocócicas com a composição antibacteriana
PE20121553A1 (es) Uso de una fuente de l3 y/o l5 como vacuna o como diagnostico para una efermedad parasitaria
PE20091781A1 (es) Uso de defensinas contra la meningitis
AR098615A1 (es) Péptido para el tratamiento de hipoglicemia severa
AR072426A1 (es) Uso de nifurtimox para el tratamiento de enfermedades causadas por tricomonadida
PE20141549A1 (es) VARIANTES DE CRIg MADURAS POR AFINIDAD
PE20160848A1 (es) Nuevo compuesto para el tratamiento de hipoglicemia severa
PE20160787A1 (es) Nuevo compuesto para el tratamiento de hipoglicemia severa

Legal Events

Date Code Title Description
FA Abandonment or withdrawal